The Board of Directors of Shanghai Labway Clinical Laboratory Co., Ltd has authorized a buyback plan on November 11, 2023.
Shanghai Labway Clinical Laboratory Co., Ltd
Equities
301060
CNE100004RG8
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.42 CNY | +1.36% | -3.34% | -21.60% |
1st Jan change | Capi. | |
---|---|---|
-21.60% | 577M | |
-16.99% | 8.55B | |
+65.23% | 4.24B | |
-1.63% | 2.54B | |
-41.76% | 2.35B | |
-8.53% | 1.89B | |
-19.29% | 1.55B | |
-39.61% | 1.23B | |
+9.54% | 1.13B | |
+19.57% | 955M |
- Stock Market
- Equities
- 301060 Stock
- News Shanghai Labway Clinical Laboratory Co., Ltd
- Shanghai Labway Clinical Laboratory Co., Ltd authorizes a Buyback Plan.